Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Technetium-99m Industry By 2029?

In recent times, there has been a significant upturn in the market size of technetium-99m. The market, which stood at $4.52 billion in 2024, is set to rise to $4.75 billion in 2025, marking a compound annual growth rate (CAGR) of 5.1%. The historical growth trend is a result of multiple factors such as the expansion of nuclear medicine applications, the surged requirement in cancer and cardiac diagnostic solutions, growing dependence on molybdenum-99 supply, an escalating demand for radiopharmaceuticals, and an increasing utilization of imaging in clinical trials.

The market size of technetium-99m is predicted to experience a constant increase over the coming years, reaching $5.74 billion by 2029 with a CAGR of 4.9%. The upsurge in the upcoming period is due to factors like the enhancement of nuclear imaging abilities, an increasingly aging population, a surge in diagnostic volume, growing cancer incidence, and increased utilization of hybrid imaging systems. Significant trends in this forecast period are the advancement in isotope technologies, the progression of non-reactor-based production, innovations in radiopharmaceutical technology, incorporation of artificial intelligence, and advancements in radiopharmaceutical production.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25920&type=smp

Which Factors Are Steering Growth In The Technetium-99m Market?

The technetium-99m market is likely to surge due to the escalating demand for diagnostic imaging procedures. Such procedures involve producing visual imagery of the body’s interior to aid physicians in diagnosing and at times, planning the treatment for numerous health conditions. The spiking demand for these imaging procedures is a result of the growing occurrences of chronic diseases which necessitate urgent and precise diagnosis. Technetium-99m plays a crucial role in these diagnostic imaging processes by enabling healthcare professionals to meticulously inspect the workings of organs and tissues, courtesy of its radioactive traits offering intricate images in nuclear medicine scans. To illustrate, the National Health Service (NHS) England, a government institution of the UK, reported in November 2023 that 45.0 million imaging examinations had been carried out in England in the year leading up to March 2023. This indicated a rise by 2.2% compared to the 44.0 million tests undertaken in the previous year. Hence, the burgeoning demand for diagnostic imaging procedures is fuelling the expansion of the technetium-99m market.

Which Segment Accounts For The Largest Share In The Technetium-99m Market?

The technetium-99m market covered in this report is segmented –

1) By Product Type: Radiopharmaceuticals, Diagnostic Kits, Generators

2) By Formulation Type: Liquid, Solid, Freeze-Dried

3) By Application: Single Photon Emission Computed Tomography (SPECT) Imaging, Positron Emission Tomography (PET) Imaging, Oncology, Cardiology, Neurology, Other Applications

4) By End-User: Hospitals, Diagnostic Imaging Centers, Research Laboratories, Specialized Clinics, Other End-Users

Subsegments:

1) By Radiopharmaceuticals: Sestamibi, Tetrofosmin, Sulfur Colloid, MAA (Macroaggregated Albumin), DTPA (Diethylenetriaminepentaacetic Acid), Others

2) By Diagnostic Kits: Cardiac Imaging Kits, Bone Imaging Kits, Renal Imaging Kits, Hepatobiliary Imaging Kits, Pulmonary Imaging Kits, Others

3) By Generators: Hospital-Based Generators, Centralized Radiopharmacy Generators

Which Long-Term Trends Will Play A Crucial Role In The Technetium-99m Market?

Key players in the technetium-99m industry are prioritizing the development of innovative solutions like advanced radiopharmaceutical imaging agents to improve the precision and availability of diagnostic imaging procedures for difficult medical conditions. Advanced radiopharmaceutical imaging agents are unique compounds marked with radioactive materials that assist doctors in viewing the body’s interior using imaging technology. An example of this is Serac Healthcare Limited’s achievement in June 2024, when this UK-based clinical radiopharmaceutical firm obtained Fast Track Designation from the US FDA for 99mTc-maraciclatide, a groundbreaking SPECT-CT imaging agent designed for visualizing and diagnosing superficial peritoneal endometriosis in women aged 16 years and above. 99mTc-maraciclatide is a technetium-99m-labeled targeted peptide imaging agent that attaches to integrins which are overexpressed in endometriosis lesions, thereby allowing clear disease site imaging during SPECT-CT scans. This provides a non-invasive alternative to laparoscopic procedures, offering a safer and more accessible diagnostic route for women suspected of having endometriosis. The agent utilizes the advantageous imaging features of technetium-99m, such as an ideal half-life and gamma emission energy, to deliver high-quality diagnostic images while limiting patients’ exposure to radiation. This novel technology is set to improve diagnostic precision and simplify treatment options in endometriosis care, and also broaden the clinical use of technetium-99m-based imaging within women’s healthcare.

Who Are The Dominant Players In The Technetium-99m Market Today?

Major companies operating in the technetium-99m market are Cardinal Health Inc., Siemens Healthineers AG, Philips Healthcare, GE Healthcare Technologies Inc., BWX Technologies Inc., Bracco Imaging S.p.A., Lantheus Holdings Inc., China Isotope & Radiation Corporation (CIRC), Jubilant Pharma Limited, Curium Pharma LLC, Eckert & Ziegler Strahlen, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Isotopia Molecular Imaging Ltd., Advanced Cyclotron Systems Inc., Cyclopharm Limited, SHINE Technologies LLC, Medi-Radiopharma Kft., SDS Lifesciences Pvt Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/technetium-99m-global-market-report

What Regional Factors Are Accelerating Growth In The Technetium-99m Market?

North America was the largest region in the technetium-99m market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the technetium-99m market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25920&type=smp

Browse Through More Reports Similar to the Global Technetium-99m Market 2025, By The Business Research Company

Regtech Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/regtech-market

Next Generation Network Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/next-generation-network-equipment-global-market-report

Neodymium Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neodymium-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model